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Biological Pathway Exchange (BioPAX) is a standard language 
to represent biological pathways at the molecular and cellular 
level and to facilitate the exchange of pathway data. The 
rapid growth of the volume of pathway data has spurred the 
development of databases and computational tools to aid 
interpretation; however, use of these data is hampered by the 
current fragmentation of pathway information across many 
databases with incompatible formats. BioPAX, which was 
created through a community process, solves this problem 
by making pathway data substantially easier to collect, 
index, interpret and share. BioPAX can represent metabolic 
and signaling pathways, molecular and genetic interactions 
and gene regulation networks. Using BioPAX, millions of 
interactions, organized into thousands of pathways, from many 
organisms are available from a growing number of databases. 
This large amount of pathway data in a computable form will 
support visualization, analysis and biological discovery.
Increasingly powerful technologies, including genome-wide molecular 
measurements, have accelerated progress toward a complete map of 
molecular interaction networks in cells and between cells of many organ-
isms. The growing scale of these maps requires their representation in 
a form suitable for computer processing, storage and dissemination 
by means of software systems. The BioPAX project aims to facilitate 
knowledge representation, systematic collection, integration and wide 
distribution of pathway data from heterogeneous information sources. 
This will enable these data to be incorporated into distributed biological 
information systems that support visualization and analysis.
BioPAX supports efforts working toward a complete representa-
tion of basic cellular processes. Biology has come a long way since 
the Boehringer-Mannheim wall chart of metabolic pathways1 and the 
Nicholson Metabolic Map2. Since then, several groups have developed 
methods and databases for organizing pathway information3–16, but 
only recently have groups collaborated as part of the BioPAX project 
to develop a generally accepted standard way of representing these 
pathway maps. Complete molecular process maps must include all 
interactions, reactions, dependencies, influence and information flow 
between pools of molecules in cells and between cells. For ease of use 
and simplicity of presentation, such network maps are often organized 
in terms of subnetworks or pathways. Pathways are models delineated 
within the entire cellular biochemical network that help us describe and 
understand specific biological processes. Thus, a useful definition of a 
pathway is a set of interactions between physical or genetic cell compo-
nents, often describing a cause-and-effect or time-dependent process, 
that explains observable biological phenomena. How do we represent 
these pathways in a generally accepted and computable form?
Challenges posed by the many fragmented pathway databases
The total volume of pathway data mapped by biologists and stored 
in databases has entered a rapid growth phase, with the number of 
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online resources for pathways and molecular interactions increasing 
70%, from 190 in 2006 to 325 in 2010 (ref. 17). In addition, molecular 
profiling methods, such as RNA profiling using microarrays, or pro-
tein quantification using mass spectrometry, provide large amounts of 
information about the dynamics of cellular pathway components and 
increase the power of pathway analysis techniques18,19. However, this 
growth poses a formidable challenge for pathway data collection and 
curation as well as for database, visualization and analysis software, 
as these data are often fragmented.
The principal motivation for building pathway databases and soft-
ware tools is to facilitate qualitative and quantitative analysis and 
modeling of large biological systems using a computational approach. 
Over 300 pathway or molecular interaction–related data resources17 
and many visualization and analysis software tools3,20–22 have been 
developed. Unfortunately, most of these databases and tools were 
originally developed to use their own pathway representation lan-
guage, resulting in a heterogeneous set of resources that are extremely 
difficult to combine and use. This has occurred because many dif-
ferent research groups, each with their own system for representing 
biomolecules and their interactions in a pathway, work independently 
to collect pathway data recorded in the literature (estimated from 
text-mining projects23 to be present in at least 10% of the >20 
million articles currently indexed by PubMed). As a result, researchers 
waste time collecting information from different sources and con-
verting it from one form of representation to another. Fragmented 
pathway data results in substantial lost opportunity cost. For instance, 
visualization and analysis tools developed for one pathway database 
cannot be reused for others, making software development efforts 
more expensive. Therefore, it is imperative to develop computational 
methods to cope with both the magnitude and fragmented nature of 
this expanding, valuable pathway information. Whereas independent 
research efforts are needed to find the best ways to represent path-
ways, community coordination and agreement on standard seman-
tics is necessary to be able to efficiently integrate pathway data from 
multiple sources on a large scale.
BioPAX requirements and implementation
A common, inclusive and computable pathway data language is 
necessary to share knowledge about pathway maps and to facilitate 
integration and use for hypothesis testing in biology24. A shared 
 language facilitates communication by reducing the number of trans-
lations required to exchange data between multiple sources (Fig. 1). 
Developing such a representation is challenging owing to the variety 
of pathways in biology and the diverse uses of pathway information. 
Pathway representations frequently use abstractions for metabolic, 
signaling, gene regulation, protein interaction and genetic interaction, 
and these serve as a starting point toward a shared language25. Also, 
several variants of this common language may be required to answer 
relevant research questions in distinct fields of biology, each covering 
unique levels of detail addressing different uses, but these should be 
rooted in common principles and must remain compatible.
BioPAX addresses these challenges. We developed BioPAX as a 
shared language to facilitate communication between diverse soft-
ware systems and to establish standard knowledge representation of 
pathway information. BioPAX supports representation of metabolic 
and signaling pathways, molecular and genetic interactions and gene 
regulation. Relationships between genes, small molecules, complexes 
and their states (e.g., post-translational protein modifications, mRNA 
splice variants, cellular location) are described, including the results 
of events. Details about the BioPAX language are available in online 
documentation at http://www.biopax.org/. The BioPAX language 
 provides terms and descriptions, to represent many aspects of biolog-
ical pathways and their annotation. It is implemented as an ontology, 
a formal system of describing knowledge (Box 1) that helps structure 
pathway data so that they are more easily processed by computer 
software (Fig. 2). It provides a standard syntax used for data exchange 
that is based on OWL (Web Ontology Language) (Box 1). Finally, it 
provides a validator that uses a set of rules to verify whether a BioPAX 
document is complete, consistent and free of common errors. BioPAX 
is the only community standard for biological pathway exchange to 
and from databases, but it is related to other standards (discussed 
below in the “What is not covered?” section).
Example of a pathway in BioPAX
Pathway models are generally described with text and with network 
diagrams. Here we use the AKT signaling pathway26,27 as an example 
to show how a typical pathway diagram that can only be interpreted 
by people (Fig. 3, top left) would be represented using BioPAX (Fig. 3, 
right). The AKT pathway is a cell surface receptor–activated signaling 
cascade that transduces external signals to intracellular events through 
a series of steps including protein-protein interactions and protein 
kinase–mediated phosphorylation. The pathway eventually activates 
transcription factors, which turn on genes to promote cell survival. 
By representing the pathway using the BioPAX language (Fig. 3 and 
Supplementary Tables 1 and 2), it can be analyzed by computational 
approaches, such as pathway analysis of gene expression data.
Representing a pathway using the BioPAX language sometimes 
necessitates being more explicit to avoid capturing inconsistent data. 
For instance, the typical notion of an ‘active protein’ is dependent 
on context, as the same molecule could be active in one cellular 
context, such as a cellular compartment with a set of potentially 
interacting molecules, and inactive in another context. Thus, captur-
ing the specific mechanism of activation, such as phosphorylation 
modification, is usually required, and the presence of downstream 
events that include the modified form signifies that the molecule is 
active. Interactions where the mechanism of action is unknown can 
also be specified.
What does BioPAX include?
BioPAX covers all major concepts familiar to biologists studying path-
ways, including metabolic and signaling pathways, gene regulatory 
networks and genetic and molecular interactions (Supplementary 
Table 3). The BioPAX language is distributed as an ontology definition 
(Fig. 4) with associated documentation, a validator for checking 
a BioPAX document for errors and other software tools (Table 1). 
Software
Database
Scientist
Efficient Communication
BioPAX
Figure 1 BioPAX is a shared language for biological pathways. BioPAX 
reduces the effort required to efficiently communicate between pathway 
users, databases and software tools. Without a shared language, each 
system must speak the language of all other systems in the worst case 
(black lines). With a shared language, each system only needs to speak 
that language (central red box).
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Pathway abstractions frequently used in several pathway databases 
and software programs are supported as follows:
• Metabolic pathways are described using the ‘enzyme, substrate, 
product’ abstraction28 where substrates and products of a biochemi-
cal reaction are often small molecules. An enzyme, often a protein, 
catalyzes the reaction, and inhibitors and activators can modulate the 
catalysis event. Metabolic pathways use BioPAX classes: PhysicalEntity, 
Conversion, Catalysis, Modulation, Pathway.
• Signaling pathways involve molecules and complexes participating 
in biochemical reactions, binding, transportation and catalysis events 
(Fig. 3)5,9,29–31. These pathways may also include descriptions of mole-
cular states (such as cellular location, covalent and noncovalent modifica-
tions, as well as fragments of sequence cleaved from a precursor) and 
generic molecules (such as the family of homologous Wnt proteins). 
Signaling pathways use BioPAX classes: PhysicalEntity, Conversion, 
Control, Catalysis, Modulation, MolecularInteraction, Pathway.
• Gene regulatory networks involve transcription and translation 
events and their control12,14. Transcription, translation and other 
template-directed reactions involving DNA or RNA are captured in a 
‘template reaction’ in BioPAX, which maps a template to its encoded 
products (e.g., DNA to mRNA). Multiple sequence regions on a 
single strand of the template, such as promoters, terminators, open 
reading frames, operons and various reaction machinery bind-
ing sites, are active in a template reaction. Transcription factors 
(generally proteins and complexes), microRNAs and other molecules, 
participate in a ‘template reaction regulation’ event. Gene regulatory 
networks use BioPAX classes: PhysicalEntity, TemplateReaction, 
TemplateReactionRegulation.
• Molecular interactions, notably protein-protein32–36 and 
protein-DNA interactions37, involve two or more ‘physical enti-
ties’. BioPAX follows the standard representation scheme of the 
Proteomics Standards Initiative Molecular Interaction (PSI-MI) 
format38. Molecular interactions use BioPAX classes: PhysicalEntity, 
MolecularInteraction.
• Genetic interactions occur between two genes when the pheno-
typic consequence of perturbing both genes is different than expected 
given the phenotypes of each single gene perturbation39. BioPAX 
 represents this as a pair of genes that participate in a ‘genetic inter-
action’ measured using an observed ‘phenotype’. Genetic interactions 
use BioPAX classes: Gene, GeneticInteraction.
Metabolic-, signaling- and gene regulatory–pathway abstractions 
are process oriented. They imply a temporal order and can be thought 
of as extensions of the standard chemical reaction pathway notation 
to accommodate biological information. Molecular and genetic inter-
actions, however, imply a static network of connections among system 
components, instead of the temporally ordered process of reactions 
that defines a metabolic or signaling pathway. BioPAX supports com-
bining these different types of data into a single model that is useful 
to gain a more complete view of a cellular process.
Data
observations
Prior models
BioPAX
ontology 
Use
Scientists
Publication about
a biological
process 
Scientist
Software
PublishData Formalize
BioPAX
record 
P
Publication about
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l
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P
Figure 2 BioPAX enables computational data gathering, publication 
and use of information about biological processes. Traditional pathway 
information processing: observations considering prior models published 
as text and figures. Computable pathway information processing: 
scientist’s description represented using formal, computable framework 
(ontology) published in a format readable by computer software for 
analysis by scientists.
Box 1 What is an ontology? 
An ontology is a formal system for representing knowledge64. Such representation is required for computer software to make use of 
information. Example ontologies include organism taxonomies65 and the Gene Ontology40. A formal representation allows consistent 
communication of knowledge among individuals or computer systems and helps manage complexity in information processing as knowl-
edge is broken down into clear concepts that can be considered independently. Ontologies also enable integration of knowledge between 
independent resources linked on the World Wide Web. Such linked, structured data form the basis of the semantic web, an extension of 
the web that promises improved information management and search capability61. Representing and sharing knowledge using ontologies 
is simplified by availability of the standard web ontology language (OWL; http://www.w3.org/TR/owl-features/). Tools to edit OWL, such 
as Protégé63, have been developed by the semantic web community and adopted in the life sciences. Implementing BioPAX using OWL 
enables both the ontology and the individuals and values to be stored in the same XML-based format, which makes data transmission 
easier. Using OWL also enables BioPAX users to take advantage of existing software tools for editing, transmitting, querying, reasoning 
about and visualizing OWL data.
An ontology is composed of classes, properties (representing relations) and restrictions and is used to define individuals (instances 
of classes, also known as objects) and values for their properties. Classes (also known as concepts or types) are often arranged into a 
 hierarchy (or taxonomy) where child classes are more specific than, and inherit the properties of, parent classes. For example, in  
BioPAX, the BiochemicalReaction class is a subclass of the Conversion class. Classes may have properties (also known as fields,  
attributes or slots), which express possible relations to other classes (that is, they may have values of specific types). For example,  
a SmallMolecule is related to the ChemicalStructure class by the property structure. Restrictions (also known as constraints) define  
allowable values and connections within an ontology. For example, molecularWeight must be a positive number. Individuals are  
instances of classes where values occupy the properties of those instances. BioPAX defines the classes, properties and restrictions  
required to represent biological pathways and leaves creation of the individuals to users (data providers and consumers).
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BioPAX provides many additional constructs, not shown in Figure 4, 
that are used to store extra details, such as database cross-references, 
chemical structure, experimental forms of molecules, sequence feature 
locations and links to controlled vocabulary terms in other ontologies 
(Supplementary Fig. 1). BioPAX reuses a number of standard controlled 
vocabularies defined by other groups. For example, Gene Ontology40 
is used to describe cellular location, PSI-MI vocabularies38 are used to 
define evidence codes, experimental forms, interaction types, relation-
ship types and sequence modifications, and Sequence Ontology41 is used 
to define types of sequence regions, such as a promoter region on DNA 
involved in transcription of a gene. Other useful controlled vocabularies 
can be referenced, such as the molecule role ontology42.
BioPAX defines additional semantics that are currently only cap-
tured in documentation. For instance, physical entities represent 
pools of molecules and not individual molecules, corresponding to 
typical semantics used when describing pathways in textbooks or 
databases. A molecular pool is a set of molecules in a bounded area 
of the cell, thus it has a concentration. Pools can be heterogeneous 
and can overlap, as in the case of a protein existing in multiple phos-
phorylation states.
BioPAX also defines a range of constructs that are represented as 
ontology classes. Some of these represent biological entities, such as 
proteins, and are organized into classes that conceptualize the path-
way knowledge domain. Others are used to represent annotations 
and properties of the database representation of biological entities. 
For instance, BioPAX provides ‘xref ’ classes to represent different 
kinds of references to databases that can be useful for data integration. 
These are represented as subclasses of UtilityClass for convenience. 
A future version of BioPAX would ideally capture these semantics 
and structure these concepts more formally.
Uses of pathway data encoded in BioPAX
Once pathway data are translated into a standard computable language, 
such as BioPAX, it is easier for software to access them and thereby 
support browsing, retrieval, visualization and analysis (Fig. 5). This 
enables efficient reuse of data in different ways, avoiding the time- 
consuming and often frustrating task of translating them between 
formats (Fig. 1). Additionally, it enables uses that would be impractical 
without a standard format, such as those dependent on combining all 
available pathway data.
BioPAX can be used to help aggregate large pathway data sets by 
reducing the required collection and translation effort, for instance 
using software such as cPath43. Typical biological queries, such as 
‘What reactions involve my protein of interest?’ generate more com-
plete answers when querying these larger pathway data sets. Another 
frequent use is to find pathways that are active in a particular bio-
logical context, such as a cell state determined by a genome-scale 
molecular profile measurement. For instance, pathways with mul-
tiple differentially expressed genes may be transcriptionally active 
in one biological condition and not in another. Functional genom-
ics and pathway data can be imported into software and combined 
for visualization and analysis to find interesting network regions. 
A typical workflow involves overlaying molecular profiling data, such 
as mRNA transcript profiles, on a network of interacting proteins 
to identify transcriptionally active network regions, which may 
represent active pathways44. A number of recent papers have used 
this pathway analysis workflow to highlight genes and pathways 
that are active in specific model organisms or diseased tissues, such 
as breast cancer, using gene and protein expression, copy number 
variants and single-nucleotide polymorphisms19,44–49. BioPAX has 
also been used in a number of these studies to collect and integrate 
large amounts of pathway information from multiple databases for 
analysis. For instance, protein expression data were combined with 
pathway information to highlight the importance of apoptosis in a 
mouse model of heart disease50. Multiple groups have found that 
tumor-associated mutations are significantly related by pathway 
Table 1 What is included in BioPAX
Content Description
Ontology specification Web Ontology Language (OWL) XML file, developed 
using free Protégé ontology editor software63.
Language documentation Explanation of BioPAX entities, example documen-
tation, best practice recommendations, use cases 
and instructions for carrying out frequently used 
technical tasks.
Example files Example files for biochemical pathway, protein and 
genetic interaction, protein phosphorylation, insulin 
maturation, gene regulation and generic molecules 
in OWL XML.
Graphical representation Recommendations for graphical representation using 
Systems Biology Graphical Notation (SBGN) as a guide.
Paxtools software Java programming library supporting import/export, 
conversion and validation. Can be used to add 
BioPAX support to software.
List of data sources and  
supporting software
Databases making data available in BioPAX format, 
software systems for storing, visualizing and 
 analyzing BioPAX pathways.
AKTAKTAKT
P
Thr308
Ser473
hsp90
PDK1
P
P
P
P
rAKT1 is a ProteinReference
has standard-name “AKT1”
has name “PKB”
has xref Uniprot-P31749
AKT1.1 is a Protein
has proteinReference rAKT1
has notFeature p@308
has notFeature p@473
reaction1 is a BiochemicalReaction
has left AKT1.2
has right AKT1.1
is left-to-right.
AKT1
AKT1
AKT1
AKT1 P
P
308
473
P
P 473
308
P
473
308
473
308
HSP90
HSP90
PDK1
PDK2
PP2A
AKT1.2 is a Protein
has proteinReference rAKT1
has feature p@308
has notFeature p@473
catalysis1 is a Catalysis
has controller PP2A.1
has controlled reaction1
has direction irr-left-to-right
assembly1 is a ComplexAssembly
has left HSP90.1
has left AKT1.3
has right complex1
is reversible
complex1 is a Complex
has component AKT1.4
has component HSP90.2
HSP90.2 is a Protein
has proteinReference rHSP90
is boundTo AKT1.4
AKT1.4 is a Protein
has proteinReference rAKT1
has feature p@308
has feature p@473
is boundTo HSP90.2
p@308 is a ModificationFeature
has featureLocation AKT1-308
has modificationType
phosphorylation
PP2A
Figure 3 The AKT pathway as represented by a traditional method (top left; 
from http://www.biocarta.com/), a formalized SBGN diagram (left; from 
http://www.sbgn.org/62) and using the BioPAX language (right). An important 
advantage of the BioPAX representation is that it can be interpreted by 
computer software and used in multiple ways, including automatic diagram 
creation, information retrieval and analysis. Online documentation at  
http://www.biopax.org/ contains more details about how to represent diverse 
types of biological pathways. Actual samples of pathway data in BioPAX 
OWL XML format are available in Supplementary Tables 1 and 2.
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information47,48. And recently, in a study of rare copy number vari-
ants in 996 individuals with autism spectrum disorder, a core set of 
neuronal development–related pathways were found to link dozens 
of rare mutations to autism that were not significantly linked to the 
disorder on their own by traditional single-gene association statis-
tics49. These studies highlight the importance of pathway information 
in explaining the functional consequence of mutations in human 
disease. BioPAX pathway data can also be converted into simula-
tion models, for instance using differential equations51 or rule-based 
modeling languages52, to predict how a biological system may func-
tion after a gene is knocked out.
BioPAX is useful for exchanging information among and between 
data providers and analysis software. Pathway database groups 
can share the effort of pathway curation by making their pathways 
available in BioPAX format and exchanging them with others. For 
example, pathways in BioPAX format from the Reactome8 database 
are imported by the US National Cancer Institute/Nature Pathway 
Information Database9. Data providers can use existing BioPAX-
enabled software to add useful new features to their systems. For 
example, the Cytoscape network visualization software20 can read and 
display BioPAX-formatted data as a network. The Reactome group 
used this feature to create a pathway visualization tool for their web-
site. Because Reactome data were available in BioPAX format, and 
Cytoscape could already read BioPAX format, this new feature was 
easy to implement.
The Paxtools Java programming library for BioPAX has been 
developed to help software developers readily support the import, 
export and validation of BioPAX-formatted data for various uses in 
their software (http://www.biopax.org/paxtools/). Using Paxtools 
and other tools, a range of BioPAX-compatible software has been 
developed, including browsers, visualizers, querying engines, 
editors and converters (Supplementary Table 4). For instance, 
the ChiBE and VisANT pathway-visualization tools read BioPAX 
format22, and the WikiPathways website53, a community wiki 
for pathways, is working on using BioPAX to help import path-
ways from several sources, including manually edited pathways 
from biologists. The Pathway Tools software21 and CellDesigner 
pathway editor54 are developing support for BioPAX-based data 
exchange. In addition, tools for the storage and querying of 
Resource Description Framework (http://www.w3.org/RDF/) data 
sets, generated within the Semantic Web community, can be used 
to effectively process BioPAX data.
What is not covered?
The BioPAX language uses a discrete repre-
sentation of biological pathways. Dynamic 
and quantitative aspects of biological proc-
esses, including temporal aspects of feedback 
loops and calcium waves, are not supported. 
However, BioPAX addresses this need by coor-
dinating work (as described below) with the 
SBML and CellML mathematical modeling language communities55,56 
and a growing software tool set supporting biological process 
 simulation57. Detailed information about experimental evidence sup-
porting elements of a pathway map is useful for evaluating the qual-
ity of pathway data. This information is only included in BioPAX for 
molecular interactions, because that was already defined by the PSI-MI 
language58 and it was reused The BioPAX work group makes use of 
PSI-MI–controlled vocabularies and other concepts and works with 
the PSI-MI work group to build these vocabularies in areas of shared 
interest, such as genetic interactions. Although BioPAX does not aim to 
standardize how pathways are visualized, work is coordinated with the 
Entity
Pathway
Interaction
TemplateReaction Control
Catalysis
TemplateReactionRegulation
Modulation Transport
DegradationTransportWithBiochemicalReaction
Biochemical
Reaction
Complex
Assembly
Conversion MolecularInteraction GeneticInteraction
Gene
Protein
DNA
RNA
PhysicalEntity
Complex
Protein properties
availability (String*)
name (String*)
-comment (String*)
xref (Xref*)
data Source (Provenance*)
evidence (Evidence*)
feature (Entity-Feature*)
not Feature (Entity-Feature*)
member Physical Entity (Protein*)
cellular Location
(Cellular-Location-Vocabulary*)
entity Reference (Protein-Reference)
Small
Molecule
Figure 4 High-level view of the BioPAX ontology. 
Classes, shown as boxes and arrows, represent 
inheritance relationships. The three main 
types of classes in BioPAX are Pathway (red), 
Interaction (green) and PhysicalEntity and  
Gene (blue). For brevity, the properties of the 
Protein class only are shown as an example at 
the top right. Asterisks indicate that multiple 
values for the property are allowed. Refer to 
BioPAX documentation at http://www.biopax.org/ 
for full details of all classes and properties.
Export Import
Pathway analysis of genomics data 
Pathway visualization from database
Data exchange between database groups
Database 1
Genomics
data 
Pathway
data 
Database 2
ExportDatabase 1 Visualization
software
Analysis
software
Find active
pathways 
AKT1
PDK1
PP2A
PDK2
HSP90
AKT1
AKT1
308
473P
P
308
473
P
308
473
Figure 5 Example uses of pathway information in BioPAX format. Red-
colored boxes or lines indicate the use of BioPAX.
©
 2
01
0 
N
at
u
re
 A
m
er
ic
a,
 In
c.
  A
ll 
ri
g
h
ts
 r
es
er
ve
d
.
940  VOLUME 28 NUMBER 9 SEPTEMBER 2010 nature biotechnology
p e r s p e c t i v e
Systems Biology Graphical Notation (SBGN; 
http://sbgn.org/) community, via members of 
both communities who attend BioPAX and 
SBGN meetings, to ensure that SBGN can be 
used to visualize BioPAX pathways. Currently, 
most BioPAX concepts can be visualized using 
SBGN process description and SBGN activity 
flow diagrams and a mapping of BioPAX to 
SBGN entity relationship diagrams is under 
development. BioPAX development is coor-
dinated with the above standardization efforts 
through regular communication between 
workgroups to ensure complementarity and 
compatibility. For instance, controlled vocab-
ularies developed by PSI-MI and BioPAX can 
be used to annotate SBML and CellML models 
(Fig. 6). BioPAX aims to be compatible with 
these and other efforts, so that pathway data 
can be transformed between alternative rep-
resentations when needed. PSI-MI to BioPAX 
and SBML to BioPAX converters are available 
(Supplementary Table 4).
How does the BioPAX community work?
Whereas BioPAX facilitates communication 
of current knowledge, it is challenging for all 
knowledge-representation efforts to anticipate new forms of informa-
tion. As new types of pathway data and new knowledge representation 
languages and tools become available, the BioPAX language must 
evolve through the efforts of a community of scientists that includes 
biologists and computer scientists.
BioPAX is developed through community consensus among data 
providers, tool developers and pathway data users. More than 15 
BioPAX workshops have been held since November 2002, attended by a 
diverse set of participants. Incremental versions, also called levels, of the 
BioPAX language were progressively developed at these workshops to 
focus the group’s efforts on attainable intermediate goals. Broader input 
came from mailing lists and a community wiki. Community members 
participated in developing functionality they were interested in, which 
was integrated into specific levels (Supplementary Table 5). Level 1 
supports metabolic pathways. Level 2 adds support for molecular inter-
actions and post-translational protein modifications by integrating data 
structures from the PSI-MI format. Level 3 adds support for signaling 
pathways, molecular state, gene regulation and genetic interactions 
(Supplementary Table 3). It is anticipated that newer BioPAX levels 
replace older ones, so use of the most recent BioPAX level 3 is currently 
recommended. To ease the burden on users and developers, BioPAX 
aims to be backwards compatible where practical. Level 2 is backwards 
compatible with level 1; however, level 3 involved a major redesign that 
necessitated breaking backwards compatibility. This said, many core 
classes have remained the same in levels 1, 2 and 3,  and software is pro-
vided for updating older BioPAX pathways to level 3 (via Paxtools). All 
BioPAX material (Table 1) is made freely available under open source 
licenses through a central website (http://www.biopax.org/) to encour-
age broad adoption. The database and tool support (Supplementary 
Table 4) of a common language aids the creation, analysis, visualization 
and interpretation of integrated pathway maps.
In addition to the creation of a shared language for data and soft-
ware, the process of achieving community consensus spurs innova-
tion in the field of pathway informatics. Community discussion helps 
resolve technical knowledge representation issues faced by many 
data providers and users and facilitates the convergence to com-
mon terminology and representation. Solutions are discovered in 
independent research groups and incorporated in new data models 
and community best practices, which then enable identification of 
new issues. Thus, community workshops support a positive feedback 
cycle of knowledge sharing that has led to an accepted BioPAX lan-
guage and development of better software and databases. We expect 
this to continue and to support new scientific uses of pathway infor-
mation, motivated by end-user access to valuable integrated pathway 
information and efficiency gain for database and software develop-
ment groups. This will especially benefit new pathway databases 
and software tools that adopt standard representation and software 
components from the start.
Future community goals
The BioPAX shared language is a starting point on the path to devel-
oping complete maps of cellular processes. Additional near and long-
term goals remain to be realized to enable effective integration and 
use of biological pathway information, as described below.
Data collection. Data must be collected and translated to a stand-
ard format for them to be integrated. This process is underway, as 
the descriptions of millions of interactions in thousands of pathways 
across many organisms from multiple databases are now available 
in BioPAX format. However, vast amounts of pathway data remain 
difficult to access in the literature and in databases that don’t yet 
support standard formats. Increasing use of standards requires pro-
moting and supporting data curation teams and automating more 
of the data collection process using software. Easy-to-use tools for 
tasks like pathway editing must also be developed so that biologists 
can share their data in BioPAX format without substantial resource 
investment. Ideally, appropriate software would allow authors to enter 
data directly in standard formats during the publication process, to 
facilitate annotation and normalization by curators before incorpora-
tion into databases for use by researchers53.
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Validation and best practice development. To aid data collection, 
major data providers and others must develop community best 
 practice guidelines and rules to help diverse groups use BioPAX con-
sistently when multiple ways of encoding the same information exist. 
This will enable data providers to benefit from automatic syntactic 
and semantic validation of their data so they can ensure they are 
sharing data using standard representation and best practices59,60. 
Data collection and automatic validation will facilitate convergence 
to generally accepted biological process models.
Semantic integration. Several models of the same biological process 
may usefully co-exist. Ideally, different models could be compared for 
analysis and hypothesis formulation. Even so, comparison is difficult 
because the same concept can be represented in several ways owing to 
use of multiple levels of abstraction (such as the hRas protein versus 
the Ras protein family), use of different controlled vocabularies, data 
incompleteness or errors. Future research needs to develop semantic 
integration solutions that recognize and aid resolution of conflicts.
Visualization. Pathway diagrams are highly useful for communicat-
ing pathway information, but it is challenging to automatically con-
struct these diagrams in a biologically intuitive way from pathway data 
stored in BioPAX. The SBGN pathway diagram standardization effort 
provides a starting point toward achieving this goal (Fig. 3). Intuitive 
and automatically drawn biological network visualizations may one 
day replace printed biology textbooks as the primary resource for 
knowledge about cellular processes.
Language evolution. As uses of pathway information and technology 
evolve, so must the BioPAX language. For instance, future BioPAX 
levels should capture cell-cell interactions, be better at describing 
pathways where sub-processes are not known or need not be repre-
sented, more closely integrate third-party controlled vocabularies and 
ontologies to ease their use and better encode semantics for easier data 
validation and reasoning.
Many groups within the BioPAX community, including most path-
way data providers and tool developers, are working to achieve the 
above goals. For instance, Pathway Commons (http://www.pathway-
commons.org/) aims to be a convenient single point of access for all 
publicly accessible pathway information and the WikiPathways project 
(http://www.wikipathways.org/) seeks to enable pathway curation by 
individuals53. Also, the semantic web community is developing a set 
of technologies that promise to ease the integration of information dis-
persed on the World Wide Web61. These technologies will aid pathway 
data integration because BioPAX is compatible with them through use 
of the W3C standard Web Ontology Language, OWL. All of the above 
research and development activities support the vision of data pro-
viders sharing computable maps of biological processes in a standard 
format for convenient use by a community of pathway researchers.
Note: Supplementary information is available on the Nature Biotechnology website.
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